Paper34909643
Tuberculosis and pharmacological interactions: A narrative review.
Riccardi N and 7 others. Curr Res Pharmacol Drug Discov, 2021. Cited by 30 papers, by iCite.
Cite this record
ConductScience Library. Tuberculosis and pharmacological interactions: A narrative review. Papers, record 34909643. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/34909643
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References94
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 1436277 | Effect of pyrazinamide on ciclosporin levels. | Nephron | 1992 | https://conductscience.org/library/papers/1436277 | PubMed |
| 2 | 32741532 | From the past, a long way to future challenges for a greater control of tuberculosis. | Tuberculosis (Edinb) | 2020 | https://conductscience.org/library/papers/32741532 | PubMed |
| 3 | 4074601 | Influence of rifampicin and isoniazid on the kinetics of phenytoin. | Br J Clin Pharmacol | 1985 | https://conductscience.org/library/papers/4074601 | PubMed |
| 4 | 9433391 | Rifampin reduces plasma concentrations and effects of zolpidem. | Clin Pharmacol Ther | 1997 | https://conductscience.org/library/papers/9433391 | PubMed |
| 5 | 21521707 | Linezolid pharmacokinetics and pharmacodynamics in clinical treatment. | J Antimicrob Chemother | 2011 | https://conductscience.org/library/papers/21521707 | PubMed |
| 6 | 18486041 | Cycloserine. | Tuberculosis (Edinb) | 2008 | https://conductscience.org/library/papers/18486041 | PubMed |
| 7 | 31729908 | Treatment of Drug-Resistant Tuberculosis. An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline. | Am J Respir Crit Care Med | 2019 | https://conductscience.org/library/papers/31729908 | PubMed |
| 8 | 26747099 | Drug-drug interactions between bedaquiline and the antiretrovirals lopinavir/ritonavir and nevirapine in HIV-infected patients with drug-resistant TB. | J Antimicrob Chemother | 2016 | https://conductscience.org/library/papers/26747099 | PubMed |
| 9 | 28240570 | Delamanid in the treatment of multidrug-resistant tuberculosis. | Int J Tuberc Lung Dis | 2016 | https://conductscience.org/library/papers/28240570 | PubMed |
| 10 | 12426514 | Rifampin markedly decreases plasma concentrations of praziquantel in healthy volunteers. | Clin Pharmacol Ther | 2002 | https://conductscience.org/library/papers/12426514 | PubMed |
| 11 | 7431585 | Rifampin and digoxin: possible drug interaction in a dialysis patient. | JAMA | 1980 | https://conductscience.org/library/papers/7431585 | PubMed |
| 12 | 11253855 | Risk assessment for antimicrobial agent-induced QTc interval prolongation and torsades de pointes. | Pharmacotherapy | 2001 | https://conductscience.org/library/papers/11253855 | PubMed |
| 13 | 14748817 | Effect of rifampicin on pravastatin pharmacokinetics in healthy subjects. | Br J Clin Pharmacol | 2004 | https://conductscience.org/library/papers/14748817 | PubMed |
| 14 | 32060065 | Bedaquiline resistance in drug-resistant tuberculosis HIV co-infected patients. | Eur Respir J | 2020 | https://conductscience.org/library/papers/32060065 | PubMed |
| 15 | 10954343 | Effects of rifampicin and cimetidine on pharmacokinetics and pharmacodynamics of lamotrigine in healthy subjects. | Eur J Clin Pharmacol | 2000 | https://conductscience.org/library/papers/10954343 | PubMed |
| 16 | 1345893 | Case report: nifedipine-rifampicin interaction attenuates the effect on blood pressure in a patient with essential hypertension. | Am J Med Sci | 1992 | https://conductscience.org/library/papers/1345893 | PubMed |
| 17 | 27270559 | Rifamycins, Alone and in Combination. | Cold Spring Harb Perspect Med | 2016 | https://conductscience.org/library/papers/27270559 | PubMed |
| 18 | 9272811 | Loss of analgesic effect of morphine due to coadministration of rifampin. | Pain | 1997 | https://conductscience.org/library/papers/9272811 | PubMed |
| 19 | 31144345 | The interaction between rifampicin and lamotrigine: A case report. | Br J Clin Pharmacol | 2019 | https://conductscience.org/library/papers/31144345 | PubMed |
| 20 | 31704175 | Pharmacological and Molecular Mechanisms Behind the Sterilizing Activity of Pyrazinamide. | Trends Pharmacol Sci | 2019 | https://conductscience.org/library/papers/31704175 | PubMed |
Cited by22
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 30 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42742880 | Exploring the impact of nutrition and autophagy on infectious diseases to inform the development of homeostatic-nanomedicines for HIV-TB coinfections. | Discov Nano | 2026 | https://conductscience.org/library/papers/42742880 | PubMed |
| 42662901 | Enrichment of CD4-CD8- cytotoxic Vδ1/3 T cells in pulmonary tuberculosis disease. | iScience | 2026 | https://conductscience.org/library/papers/42662901 | PubMed |
| 40869505 | Tuberculosis in Pregnant Women After COVID-19: Features of Prevention, Diagnosis, and Treatment (Narrative Review). | J Clin Med | 2025 | https://conductscience.org/library/papers/40869505 | PubMed |
| 40727383 | Pharmacokinetic Profile of Isoniazid and Acetylator Status in Patients with Systemic Lupus Erythematosus: Implications for Tuberculosis Prevention Therapy in Indonesia. | Infect Drug Resist | 2025 | https://conductscience.org/library/papers/40727383 | PubMed |
| 40654283 | Gut microbiota and tuberculosis infection: interaction and therapeutic potential. | Gut Microbes | 2025 | https://conductscience.org/library/papers/40654283 | PubMed |
| 40176807 | Recent advances in immunopathogenesis and clinical practice: mastering the challenge-managing of non-tuberculous mycobacteria. | Front Immunol | 2025 | https://conductscience.org/library/papers/40176807 | PubMed |
| 40104255 | The importance of getting the dose right in the treatment of tuberculosis. | Breathe (Sheff) | 2025 | https://conductscience.org/library/papers/40104255 | PubMed |
| 40060746 | The risk of developing depression in tuberculosis survivors: a nationwide cohort study in South Korea. | Front Psychiatry | 2025 | https://conductscience.org/library/papers/40060746 | PubMed |
| 39697659 | Combination of gallium citrate and levofloxacin induces a distinct metabolome profile and enhances growth inhibition of multidrug-resistant Mycobacterium tuberculosis compared to linezolid. | Front Microbiol | 2024 | https://conductscience.org/library/papers/39697659 | PubMed |
| 39234233 | ISCCM Position Statement on the Approach to and Management of Critically Ill Patients with Tuberculosis. | Indian J Crit Care Med | 2024 | https://conductscience.org/library/papers/39234233 | PubMed |
| 39204140 | Drug-Drug Interactions between COVID-19 and Tuberculosis Medications: A Comprehensive Review of CYP450 and Transporter-Mediated Effects. | Pharmaceuticals (Basel) | 2024 | https://conductscience.org/library/papers/39204140 | PubMed |
| 38783925 | Breaking barriers: The potential of nanosystems in antituberculosis therapy. | Bioact Mater | 2024 | https://conductscience.org/library/papers/38783925 | PubMed |
| 38766427 | Tuberculosis-diabetes comorbidities: Mechanistic insights for clinical considerations and treatment challenges. | World J Diabetes | 2024 | https://conductscience.org/library/papers/38766427 | PubMed |
| 38136767 | How We Treat Drug-Susceptible Pulmonary Tuberculosis: A Practical Guide for Clinicians. | Antibiotics (Basel) | 2023 | https://conductscience.org/library/papers/38136767 | PubMed |
| 37987471 | Potential Drug-Drug Interactions and Related Factors among Geriatric Outpatients of a Tertiary Care Hospital. | Geriatrics (Basel) | 2023 | https://conductscience.org/library/papers/37987471 | PubMed |
| 37547037 | Tuberculosis in older adults: challenges and best practices in the Western Pacific Region. | Lancet Reg Health West Pac | 2023 | https://conductscience.org/library/papers/37547037 | PubMed |
| 37508267 | Management of Polypharmacy and Potential Drug-Drug Interactions in Patients with Mycobacterial Infection: A 1-Year Experience of a Multidisciplinary Outpatient Clinic. | Antibiotics (Basel) | 2023 | https://conductscience.org/library/papers/37508267 | PubMed |
| 36538813 | Advances in the design of combination therapies for the treatment of tuberculosis. | Expert Opin Drug Discov | 2023 | https://conductscience.org/library/papers/36538813 | PubMed |
| 36105740 | Pretomanid for tuberculosis treatment: an update for clinical purposes. | Curr Res Pharmacol Drug Discov | 2022 | https://conductscience.org/library/papers/36105740 | PubMed |
| 35650702 | Clinical standards for the dosing and management of TB drugs. | Int J Tuberc Lung Dis | 2022 | https://conductscience.org/library/papers/35650702 | PubMed |
Genes13
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/34909643
GET https://conductscience.org/api/papers/v1/34909643/references?page=2